Chicago, IL 的 第二型糖尿病 臨床試驗
19 項針對 第二型糖尿病 的研究正在 Chicago（約 30 英里範圍內）及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本（英文）
正在為研究招募對象嗎？將此頁面置頂展示 — $99 / 30 天 →
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
招募中3 期
- Cedar Crosse Research Center, Chicago
A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events
招募中歡迎健康志工
- Northwestern University, Chicago
A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity
招募中3 期
- Cedar Crosse Research Center, Chicago
- Northwestern University, Chicago
A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus
招募中3 期
- Research Site, Chicago
A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
招募中3 期
- Research Site, Chicago
A Study of CX11 Tablets in Patients With Type 2 Diabetes Mellitus
招募中2 期
- AES - DRS - Synexus Clinical Research US, Inc. - Chicago, Chicago
A Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 Diabetes
招募中2 期
- Cedar-Crosse Research Center, Chicago
Study to Assess the Effects of ALN-ANG3 in Adult Participants With Diabetic Kidney Disease
招募中2 期
- Research by Design, LLC - Internal Medicine, Chicago
Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)
招募中2 期
- Chicago Clinical Research Institute, Chicago
A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus and Impaired Renal Function on Background Dapagliflozin
招募中3 期
- Research Site, Chicago
A Phase III Study to Investigate the Efficacy and Safety of the Combination of Elecoglipron and Dapagliflozin in Adults With Type 2 Diabetes Mellitus
招募中3 期
- Research Site, Chicago
A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD4248 in Healthy Participants and Participants With Chronic Kidney Disease and Type 2 Diabetes and to Assess Home Measurements of Creatinine in a Non Interventional Cohort
招募中1 期歡迎健康志工
- Research Site, Chicago
A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)
招募中3 期
- University of Illinois at Chicago, Chicago
Efficacy of the Omnipod® 6 System Compared With the Omnipod® 5 System
招募中
- Northwestern University, Chicago
Evaluation of the Fully Closed Loop Omnipod® System in Type 2 Diabetes
招募中
- Northwestern University, Chicago
Achieving Routine Intervention and Screening for Emotional Health
招募中
- University of Chicago, Chicago
Mathematical Modeling of Blood Sugar and Hormone Responses in Insulin-Dependent Type 2 Diabetes
招募中觀察性研究
- Illinois Institute of Technology, Chicago
Enhancing Diabetes Care: Exposome &Amp; Sensors
招募中觀察性研究
- University of Illinois - Chicago, Chicago
- University of Illinois College of Nursing, Chicago
My ESSENCE - A Research Study on Mindfulness for African-Americans With Type 2 Diabetes
招募中歡迎健康志工
- University of Illinois at Chicago, Chicago
其他城市的 第二型糖尿病 試驗
- San Antonio, TX37 項研究
- Houston, TX31 項研究
- Orlando, FL24 項研究
- Boston, MA20 項研究
- Miami, FL19 項研究
- Dallas, TX19 項研究
- Columbus, OH18 項研究
- Las Vegas, NV18 項研究
- Atlanta, GA17 項研究
- San Diego, CA17 項研究
- Los Angeles, CA16 項研究
- New York City, NY16 項研究
Chicago 的其他研究
- 非小細胞肺癌61 項研究
- 乳癌58 項研究
- 癌症（所有類型）51 項研究
- 轉移性癌症45 項研究
- 前列腺癌45 項研究
- 肥胖症41 項研究
- 肺癌41 項研究
- 卵巢癌36 項研究
- 中風34 項研究
- 大腸直腸癌33 項研究
- 心臟衰竭31 項研究
- 過重28 項研究
資料來源：ClinicalTrials.gov，擷取日期 2026年10月5日。各研究自行設定資格標準；由研究團隊決定參與者資格。